Bienes Cambio Fecha
AbbVie USD 147.68B 12.57B 2026-09
Aena EUR 19.71B 911.52M 2026-09
Alcon AG USD 31.1B 521M 2026-06
Almirall EUR 2.37B 29.97M 2026-06
Amarin USD 634.08M 9.72M 2026-09
Amgen USD 96.05B 409M 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Bayer EUR 113.47B 6.18B 2026-09
Biogen USD 32.05B 32.5M 2026-09
BMW EUR 272.99B 2.37B 2026-06
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Eli Lilly USD 148.07B 5.79B 2026-09
Essilor EUR 65.06B 1.16B 2026-06
Fresenius EUR 42.24B 401M 2026-09
Fresenius Medical Care EUR 31.29B 174.35M 2026-06
Genmab DKK 12.52B 139M 2026-06
Gilead Sciences USD 51.41B 2.05B 2026-09
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
GRIFOLS EUR 20.28B 191M 2026-09
Hikma Pharmaceutical USD 5.67B 117M 2025-12
J&J USD 197.42B 3.64B 2026-09
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Lonza CHF 18.97B 164M 2025-12
Mercedes-Benz AG EUR 256.42B 3.3B 2026-09
Merck EUR 52.69B 383M 2026-06
Merck USD 132.77B 2.97B 2026-09
Novartis USD 117.15B 4.88B 2026-09
Novo Nordisk DKK 594.94B 35.72B 2026-06
Orion EUR 2.03B 160.3M 2026-09
Pfizer USD 204.54B 3.41B 2026-09
Philips EUR 26.7B 565M 2026-06
Recordati EUR 5.37B 33.76M 2026-06
Regeneron Pharmaceuticals USD 44.41B 2.67B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
Sanofi EUR 130.29B 1.23B 2026-09
Sanofi EUR 129.06B 1.04B 2026-06
SAP EUR 76.34B 727M 2026-09
UCB EUR 18.16B 971M 2025-12
Vinci EUR 134.87B 1.8B 2026-06
Volkswagen EUR 661.41B 7.93B 2026-09